Clinical parameters predicting development of pulmonary malignancies in patients treated for head and neck squamous cell carcinoma

6Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background As the locoregional control rates in head and neck squamous cell carcinoma (HNSCC) have increased, these patients may suffer distant metastasis in a higher proportion of cases. Clinicopathological characteristics allowing prediction of high-risk profile would allow adapting posttreatment surveillance to individual risk. Methods A retrospective review of all patients with HNSCC treated at the Jewish General Hospital, McGill University, Montreal, Quebec, Canada, between 1999 and 2008 was conducted for this study. Results The study included 428 patients with a mean follow-up of 65 months (±SEM 1.7). Eighty patients (18.6%) developed pulmonary malignancy during follow-up. In multivariate Cox-regression analysis, locoregional failure and current smoking were associated with higher risk of pulmonary malignancy (p

Cite

CITATION STYLE

APA

Madana, J., Morand, G. B., Alrasheed, A., Gabra, N., Laliberté, F., Barona-Lleó, L., … Hier, M. P. (2016). Clinical parameters predicting development of pulmonary malignancies in patients treated for head and neck squamous cell carcinoma. Head and Neck, 38, E1277–E1280. https://doi.org/10.1002/hed.24210

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free